Skip to content
GLP-1 Desk
Menu
Dispatch #36

Care Bare Rx

Oral as well as injectable routes for both molecules, plus a real brand Ozempic lane, bundled with hair, TRT and sexual health.

Visit Care Bare RxAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
From $199/mo (shared weight-loss price)
Tirzepatide
From $199/mo (shared weight-loss price)
Coverage
Multi-state
Brand-name
Yes

Weigh Care Bare Rx against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency60/100
State access70/100
Molecule range94/100
Onboarding speed76/100
Support responsiveness74/100
Licensing & trust84/100

What the Desk likes

  • Oral tirzepatide as well as injectable — rare on this board
  • Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
  • LegitScript certified and HIPAA compliant
  • One platform if you also want hair, TRT, sexual health or NAD+

Where points come off

  • The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
  • Per-dose pricing is quiz-gated, so a titrated monthly cost cannot be modelled beforehand
  • No named clinicians, founding year or parent company disclosed
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are

The Desk's briefing — C

Best for: People consolidating several telehealth needs who will accept quiz-gated pricing to get oral tirzepatide.

Care Bare Rx ranks #36 of 42 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (35)

Pricing and verification reflect Care Bare Rx's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Care Bare Rx's site. Not medical advice; see our disclosure.

← Back to The Desk